Terms: = Ovarian cancer AND PPARG, PPARG1, 5468, ENSG00000132170, PPARG2, NR1C3, HUMPPARG
10 results:
1. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.
Guan HR; Li B; Zhang ZH; Wu HS; He XL; Dong YJ; Su J; Lv GY; Chen SH
BMC Complement Med Ther; 2023 Dec; 23(1):458. PubMed ID: 38102584
[TBL] [Abstract] [Full Text] [Related]
2. Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
Clamp AR; James EC; McNeish IA; Dean A; Kim JW; O'Donnell DM; Gallardo-Rincon D; Blagden S; Brenton J; Perren TJ; Sundar S; Lord R; Dark G; Hall M; Banerjee S; Glasspool RM; Hanna CL; Williams S; Scatchard KM; Nam H; Essapen S; Parkinson C; McAvan L; Swart AM; Popoola B; Schiavone F; Badrock J; Fananapazir F; Cook AD; Parmar M; Kaplan R; Ledermann JA
Lancet Oncol; 2022 Jul; 23(7):919-930. PubMed ID: 35690073
[TBL] [Abstract] [Full Text] [Related]
3. A Network Pharmacology-Based Analysis of Multi-Target, Multi-Pathway, Multi-Compound Treatment for ovarian Serous Cystadenocarcinoma.
Xiong DD; Qin Y; Xu WQ; He RQ; Wu HY; Wei DM; Zeng JJ; Dang YW; Chen G
Clin Drug Investig; 2018 Oct; 38(10):909-925. PubMed ID: 30097905
[TBL] [Abstract] [Full Text] [Related]
4. High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.
Zhu L; Feng H; Jin S; Tan M; Gao S; Zhuang H; Hu Z; Wang H; Song Z; Lin B
Tumour Biol; 2017 Jul; 39(7):1010428317711655. PubMed ID: 28671040
[TBL] [Abstract] [Full Text] [Related]
5. Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.
Cao WM; Gao Y; Yang HJ; Xie SN; Ding XW; Pan ZW; Ye WW; Wang XJ
BMC Cancer; 2016 Feb; 16():64. PubMed ID: 26852015
[TBL] [Abstract] [Full Text] [Related]
6. Association between genetic polymorphisms of inflammatory response genes and the risk of ovarian cancer.
Lu ZH; Gu XJ; Shi KZ; Li X; Chen DD; Chen L
J Formos Med Assoc; 2016 Jan; 115(1):31-7. PubMed ID: 25659662
[TBL] [Abstract] [Full Text] [Related]
7. CYP19A1 promoter methylation in saliva associated with milestones of pubertal timing in urban girls.
Stueve TR; Wolff MS; Pajak A; Teitelbaum SL; Chen J
BMC Pediatr; 2014 Mar; 14():78. PubMed ID: 24649863
[TBL] [Abstract] [Full Text] [Related]
8. Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer.
Ivan C; Hu W; Bottsford-Miller J; Zand B; Dalton HJ; Liu T; Huang J; Nick AM; Lopez-Berestein G; Coleman RL; Baggerly KA; Sood AK
Gynecol Oncol; 2013 Mar; 128(3):506-11. PubMed ID: 23200915
[TBL] [Abstract] [Full Text] [Related]
9. Pharmacological targeting of mammalian target of rapamycin inhibits ovarian granulosa cell tumor growth.
Rico C; Laguë MN; Lefèvre P; Tsoi M; Dodelet-Devillers A; Kumar V; Lapointe E; Paquet M; Nadeau MÈ; Boerboom D
Carcinogenesis; 2012 Nov; 33(11):2283-92. PubMed ID: 22871496
[TBL] [Abstract] [Full Text] [Related]
10. Specific unsaturated fatty acids enforce the transdifferentiation of human cancer cells toward adipocyte-like cells.
Ruiz-Vela A; Aguilar-Gallardo C; Martínez-Arroyo AM; Soriano-Navarro M; Ruiz V; Simón C
Stem Cell Rev Rep; 2011 Nov; 7(4):898-909. PubMed ID: 21499706
[TBL] [Abstract] [Full Text] [Related]